Lentiviral vectors: Are they the future of animal transgenesis?

Physiological Genomics

Volumn 31, Issue 2, 2007, Pages 159-173

  Park, Frank ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Integration; Lentiviral vector; Progeny; Transgenic animals

Indexed keywords

GENOMIC DNA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PLASMID DNA; VIRUS RNA;

CELL NUCLEUS TRANSPLANTATION; DNA MODIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GENE TRANSFER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; MICROINJECTION; MOLONEY LEUKEMIA ONCOVIRUS; MOSAICISM; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGENY; RETROVIRUS; REVIEW; SPERMATOGONIUM; TRANSGENIC ANIMAL; TRANSGENICS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIRDS; DEFECTIVE VIRUSES; DNA, RECOMBINANT; EMBRYO TRANSFER; EPIGENESIS, GENETIC; FEMALE; GENE THERAPY; GENES, VIRAL; GENETIC VECTORS; LENTIVIRUS; MALE; MAMMALS; MICROINJECTIONS; NUCLEAR TRANSFER TECHNIQUES; SPECIES SPECIFICITY; SPERMATOZOA; TRANSDUCTION, GENETIC; TRANSGENES; VIRUS INTEGRATION;

ANIMALIA; MAMMALIA;

EID: 35548970311     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00069.2007     Document Type: Review

References (146)

1. al-Shawi R, Kinnaird J, Burke J, Bishop JO. Expression of a foreign gene in a line of transgenic mice is modulated by a chromosomal position effect. Mol Cell Biol 10: 1192-1198, 1990.
2. Bank A, Dorazio R, Leboulch P. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia. Ann NY Acad Sci 1054: 308-316, 2005.
3. Bishop JO. Chromosomal insertion of foreign DNA. Reprod Nutr Dev 36: 607-618, 1996.
4. Bishop JO, Smith P. Mechanism of chromosomal integration of microinjected DNA. Mol Biol Med 6: 283-298, 1989.
5. Bondioli KR, Biery KA, Hill KG, Jones KB, De Mayo FJ. Production of transgenic cattle by pronuclear injection. Biotechnology 16: 265-273, 1991.
6. Brackett BG, Baranska W, Sawicki W, Koprowski H. Uptake of heterologous genome by mammalian spermatozoa and its transfer to ova through fertilization. Proc Natl Acad Sci USA 68: 353-357, 1971.
7. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82: 4438-4442, 1985.
8. Brinster RL, Sandgren EP, Behringer RR, Palmiter RD. No simple solution for making transgenic mice. Cell 59: 239-241, 1989.
9. Bryda EC, Pearson M, Agca Y, Bauer BA. Method for detection and identification of multiple chromosomal integration sites in transgenic animals created with lentivirus. Biotechniques 41: 715-719, 2006.
10. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 90: 8033-8037, 1993.
11. Cabot RA, Kuhholzer B, Chan AW, Lai L, Park KW, Chong KY, Schatten G, Murphy CN, Abeydeera LR, Day BN, Prather RS. Transgenic pigs produced using in vitro matured oocytes infected with a retroviral vector. Anim Biotechnol 12: 205-214, 2001.
12. Chan AW. Transgenic animals: current and alternative strategies. Cloning 1: 25-46, 1999.
13. Chan AW, Chong KY, Martinovich C, Simerly C, Schatten G. Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 291: 309-312, 2001.
14. Chan AW, Homan EJ, Ballou LU, Burns JC, Bremel RD. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc Natl Acad Sci USA 95: 14028-14033, 1998.
15. Chapman SC, Lawson A, Macarthur WC, Wiese RJ, Loechel RH, Burgos-Trinidad M, Wakefield JK, Ramabhadran R, Mauch TJ, Schoenwolf GC. Ubiquitous GFP expression in transgenic chickens using a lentiviral vector. Development 132: 935-940, 2005.
16. Cheng TC, Hanley TA, Mudd J, Merlie JP, Olson EN. Mapping of myogenin transcription during embryogenesis using transgenes linked to the myogenin control region. J Cell Biol 119: 1649-1656, 1992.
17. Chevalier-Mariette C, Henry I, Montfort L, Capgras S, Forlani S, Muschler J, Nicolas JF. CpG content affects gene silencing in mice: evidence from novel transgenes. Genome Biol 4: R53, 2003.
18. Cockrell AS, Kafri T. HIV-1 vectors: fulfillment of expectations, further advancements, and still a way to go. Curr HIV Res 1: 419-439, 2003.
19. Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5: 387-398, 2005.
20. Dalle B, Rubin JE, Alkan O, Sukonnik T, Pasceri P, Yao S, Pawliuk R, Leboulch P, Ellis J. eGFP reporter genes silence LCRbeta-globin transgene expression via CpG dinucleotides. Mol Ther 11: 591-599, 2005.
21. Dann CT, Alvarado AL, Hammer RE, Garbers DL. Heritable and stable gene knockdown in rats. Proc Natl Acad Sci USA 103: 11246-11251, 2006.
22. De Miguel MP, Donovan PJ. Determinants of retroviral-mediated gene delivery to mouse spermatogonia. Biol Reprod 68: 860-866, 2003.
23. De Palma M, Montini E, Santoni de Sio FR, Benedicenti F, Gentile A, Medico E, Naldini L. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105: 2307-2315, 2005.
24. Ebert KM, Selgrath JP, DiTullio P, Denman J, Smith TE, Memon MA, Schindler JE, Monastersky GM, Vitale JA, Gordon K. Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression. Biotechnology 9: 835-838, 1991.
25. Ellis J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16: 1241-1246, 2005.
26. Emery DW, Yannaki E, Tubb J, Nishino T, Li Q, Stamatoyannopoulos G. Development of virus vectors for gene therapy of beta chain hemoglobinopathies: flanking with a chromatin insulator reduces gammaglobin gene silencing in vivo. Blood 100: 2012-2019, 2002.
27. Emery DW, Yannaki E, Tubb J, Stamatoyannopoulos G. A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci USA 97: 9150-9155, 2000.
28. Escarpe P, Zayek N, Chin P, Borellini F, Zufferey R, Veres G, Kiermer V. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther 8: 332-341, 2003.
29. Everett RS, Evans HK, Hodges BL, Ding EY, Serra DM, Amalfitano A. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors. Virology 325: 96-105, 2004.
30. Ewerling S, Hofmann A, Klose R, Weppert M, Brem G, Rink K, Pfeifer A, Wolf E. Evaluation of laser-assisted lentiviral transgenesis in bovine. Transgenic Res 15: 447-454, 2006.
31. Filipiak WE, Saunders TL. Advances in transgenic rat production. Transgenic Res 15: 673-686, 2006.
32. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25: 217-222, 2000.
33. Giraldo P, Montoliu L. Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 10: 83-103, 2001.
34. Golding MC, Long CR, Carmell MA, Hannon GJ, Westhusin ME. Suppression of prion protein in livestock by RNA interference. Proc Natl Acad Sci USA 103: 5285-5290, 2006.
35. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77: 7380-7384, 1980.
36. Guo ZS, Wang LH, Eisensmith RC, Woo SL. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther 3: 802-810, 1996.
37. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256, 2003.
38. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419, 2003.
39. Hacker CV, Vink CA, Wardell TW, Lee S, Treasure P, Kingsman SM, Mitrophanous KA, Miskin JE. The integration profile of EIAV-based vectors. Mol Ther 14: 536-545, 2006.
40. Hammer RE, Pursel VG, Rexroad CE Jr, Wall RJ, Bolt DJ, Ebert KM, Palmiter RD, Brinster RL. Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315: 680-683, 1985.
41. Hamra FK, Gatlin J, Chapman KM, Grellhesl DM, Garcia JV, Hammer RE, Garbers DL. Production of transgenic rats by lentiviral transduction of male germ-line stem cells. Proc Natl Acad Sci USA 99: 14931-14936, 2002.
42. Hannon GJ. RNA interference. Nature 418: 244-251, 2002.
43. Hematti P, Hong BK, Ferguson C, Adler R, Hanawa H, Sellers S, Holt IE, Eckfeldt CE, Sharma Y, Schmidt M, von Kalle C, Persons DA, Billings EM, Verfaillie CM, Nienhuis AW, Wolfsberg TG, Dunbar CE, Calmels B. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol 2: e423, 2004.
44. Hewlett IK, Geyer SJ, Hawthorne CA, Ruta M, Epstein JS. Kinetics of early HIV-1 gene expression in infected H9 cells assessed by PCR. Oncogene 6: 491-493, 1991.
45. Hino S, Fan J, Taguwa S, Akasaka K, Matsuoka M. Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure. Gene Ther 11: 819-828, 2004.
46. Hirabayashi M, Takahashi R, Ito K, Kashiwazaki N, Hirao M, Hirasawa K, Hochi S, Ueda M. A comparative study on the integration of exogenous DNA into mouse, rat, rabbit, and pig genomes. Exp Anim 50: 125-131, 2001.
47. Hofmann A, Kessler B, Ewerling S, Kabermann A, Brem G, Wolf E, Pfeifer A. Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol Ther 13: 59-66, 2006.
48. Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, Stojkovic M, Boelhauve M, Brem G, Wolf E, Pfeifer A. Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep 4: 1054-1060, 2003.
49. Hofmann A, Zakhartchenko V, Weppert M, Sebald H, Wenigerkind H, Brem G, Wolf E, Pfeifer A. Generation of transgenic cattle by lentiviral gene transfer into oocytes. Biol Reprod 71: 405-409, 2004.
50. Hollis RP, Stoll SM, Sclimenti CR, Lin J, Chen-Tsai Y, Calos MP. Phage integrases for the construction and manipulation of transgenic mammals. Reprod Biol Endocrinol 1: 79, 2003.
51. Humeau LM, Binder GK, Lu X, Slepushkin V, Merling R, Echeagaray P, Pereira M, Slepushkina T, Barnett S, Dropulic LK, Carroll R, Levine BL, June CH, Dropulic B. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther 9: 902-913, 2004.
52. Ikawa M, Tanaka N, Kao WW, Verma IM. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther 8: 666-673, 2003.
53. Jacoby J. Interview with Dr. Verma. Gene Ther 12: 950-953, 2005.
54. Jaenisch R. Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc Natl Acad Sci USA 73: 1260-1264, 1976.
55. Jaenisch R, Fan H, Croker B. Infection of preimplantation mouse embryos and of newborn mice with leukemia virus: tissue distribution of viral DNA and RNA and leukemogenesis in the adult animal. Proc Natl Acad Sci USA 72: 4008-4012, 1975.
56. Jaenisch R, Harbers K, Jahner D, Stewart C, Stuhlmann H. DNA methylation, retroviruses, and embryogenesis. J Cell Biochem 20: 331-336, 1982.
57. Jahner D, Jaenisch R. Integration of Moloney leukaemia virus into the germ line of mice: correlation between site of integration and virus activation. Nature 287: 456-458, 1980.
58. Kanatsu-Shinohara M, Toyokuni S, Shinohara T. Genetic selection of mouse male germline stem cells in vitro: offspring from single stem cells. Biol Reprod 72: 236-240, 2005.
59. Kang Y, Stein CS, Heth JA, Sinn PL, Penisten AK, Staber PD, Ratliff KL, Shen H, Barker CK, Martins I, Sharkey CM, Sanders DA, McCray PB Jr, Davidson BL. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76: 9378-9388, 2002.
60. Karpen GH. Position-effect variegation and the new biology of heterochromatin. Curr Opin Genet Dev 4: 281-291, 1994.
61. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40, 2001.
62. Kay MA, Li Q, Liu TJ, Leland F, Toman C, Finegold M, Woo SL. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gene Ther 3: 641-647, 1992.
63. Kissler S, Stern P, Takahashi K, Hunter K, Peterson LB, Wicker LS. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet 38: 479-483, 2006.
64. Kitagawa R, Miyachi S, Hanawa H, Takada M, Shimada T. Differential characteristics of HIV-based versus SIV-based lentiviral vector systems: gene delivery to neurons and axonal transport of expressed gene. Neurosci Res 57: 550-558, 2007.
65. Kohn DB. Lentiviral vectors ready for prime-time. Nat Biotechnol 25: 65-66, 2007.
66. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM. Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA 100: 1298-1303, 2003.
67. Kues WA, Schwinzer R, Wirth D, Verhoeyen E, Lemme E, Herrmann D, Barg-Kues B, Hauser H, Wonigeit K, Niemann H. Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs. FASEB J 20: 1200-1202, 2006.
68. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 12: 1893-1905, 2001.
69. Laufs S, Guenechea G, Gonzalez-Murillo A, Zsuzsanna Nagy K, Luz Lozano M, del Val C, Jonnakuty S, Hotz-Wagenblatt A, Jens Zeller W, Bueren JA, Fruehauf S. Lentiviral vector integration sites in human NOD/SCID repopulating cells. J Gene Med 8: 1197-1207, 2006.
70. Lavitrano M, Camaioni A, Fazio VM, Dolci S, Farace MG, Spadafora C. Sperm cells as vectors for introducing foreign DNA into eggs: genetic transformation of mice. Cell 57: 717-723, 1989.
71. Levine BL, Humeau LM, Boyer J, MacGregor RR, Rebello T, Lu X, Binder GK, Slepushkin V, Lemiale F, Mascola JR, Bushman FD, Dropulic B, June CH. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 103: 17372-17377, 2006.
72. Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli S, Verdin E, Berry CC, Ecker JR, Bushman FD. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79: 6610-6619, 2005.
73. Lillico SG, Sherman A, McGrew MJ, Robertson CD, Smith J, Haslam C, Barnard P, Radcliffe PA, Mitrophanous KA, Elliot EA, Sang HM. Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci USA 104: 1771-1776, 2007.
74. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872, 2002.
75. Lu W, Yamamoto V, Ortega B, Baltimore D. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119: 97-108, 2004.
76. Ma Y, Ramezani A, Lewis R, Hawley RG, Thomson JA. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21: 111-117, 2003.
77. MacDonald RJ, Hammer RE, Swift GH, Davis BP, Brinster RL. Transgenic progeny inherit tissue-specific expression of rat elastase I genes. DNA 5: 393-401, 1986.
78. Manilla P, Rebello T, Afable C, Lu X, Slepushkin V, Humeau LM, Schonely K, Ni Y, Binder GK, Levine BL, MacGregor RR, June CH, Dropulic B. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16: 17-25, 2005.
79. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713: 99-107, 1996.
80. McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H. Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 5: 728-733, 2004.
81. Michalkiewicz M, Michalkiewicz T, Geurts AM, Roman RJ, Slocum GR, Singer O, Weihrauch D, Greene AS, Kaldunski ML, Verma IM, Jacob HJ, Cowley AW Jr. Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol 293: H881-H894, 2007.
82. Mitchell RS, Beitzel BF, Schroder AR, Shinn P, Chen H, Berry CC, Ecker JR, Bushman FD. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234, 2004.
83. Mohamedali A, Moreau-Gaudry F, Richard E, Xia P, Nolta J, Malik P. Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells. Mol Ther 10: 249-259, 2004.
84. Montini E, Cesana D, Schmidt M, Sanvito F, Ponzoni M, Bartholomae C, Sergi Sergi L, Benedicenti F, Ambrosi A, Di Serio C, Doglioni C, von Kalle C, Naldini L. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24: 687-696, 2006.
85. Moreira PN, Giraldo P, Cozar P, Pozueta J, Jimenez A, Montoliu L, Gutierrez-Adan A. Efficient generation of transgenic mice with intact yeast artificial chromosomes by intracytoplasmic sperm injection. Biol Reprod 71: 1943-1947, 2004.
86. Moreira PN, Pozueta J, Giraldo P, Gutierrez-Adan A, Montoliu L. Generation of yeast artificial chromosome transgenic mice by intracytoplasmic sperm injection. Methods Mol Biol 349: 151-161, 2006.
87. Nagano M, Shinohara T, Avarbock MR, Brinster RL. Retrovirus-mediated gene delivery into male germ line stem cells. FEBS Lett 475: 7-10, 2000.
88. Nagano M, Watson DJ, Ryu BY, Wolfe JH, Brinster RL. Lentiviral vector transduction of male germ line stem cells in mice. FEBS Lett 524: 111-115, 2002.
89. Nagata M, Takahashi M, Muramatsu S, Ueda Y, Hanazono Y, Takeuchi K, Okada K, Suzuki Y, Kondo Y, Suemori M, Ikeda U, Nakano I, Kobayashi E, Hasegawa M, Ozawa K, Nakatsuji N, Shimada K. Efficient gene transfer of a simian immuno-deficiency viral vector into cardiomyocytes derived from primate embryonic stem cells. J Gene Med 5: 921-928, 2003.
90. Nakagawa T, Feliu-Mojer MI, Wulf P, Lois C, Sheng M, Hoogenraad CC. Generation of lentiviral transgenic rats expressing glutamate receptor interacting protein 1 (GRIP1) in brain, spinal cord and testis. J Neurosci Methods 152: 1-9, 2006.
91. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267, 1996.
92. Naviaux RK, Verma IM. Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol 3: 540-547, 1992.
93. Ohashi K, Park F, Kay MA. Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum Gene Ther 13: 653-663, 2002.
94. Ohashi K, Park F, Schwall R, Kay M. Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector. Transplant Proc 34: 1431-1433, 2002.
95. Okada Y, Ueshin Y, Isotani A, Saito-Fujita T, Nakashima H, Kimura K, Mizoguchi A, Oh-Hora M, Mori Y, Ogata M, Oshima RG, Okabe M, Ikawa M. Complementation of placental defects and embryonic lethality by trophoblast-specific lentiviral gene transfer. Nat Biotechnol 25: 233-237, 2007.
96. Pannell D, Ellis J. Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol 11: 205-217, 2001.
97. Pannell D, Osborne CS, Yao S, Sukonnik T, Pasceri P, Karaiskakis A, Okano M, Li E, Lipshitz HD, Ellis J. Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 19: 5884-5894, 2000.
98. Park F. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice. Hum Gene Ther 14: 1489-1494, 2003.
99. Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther 4: 164-173, 2001.
100. Park F, Ohashi K, Chiu W, Naldini L, Kay MA. Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24: 49-52, 2000.
101. Park F, Ohashi K, Kay MA. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther 8: 314-323, 2003.
102. Park F, Ohashi K, Kay MA. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 96: 1173-1176, 2000.
103. Perry AC, Wakayama T, Kishikawa H, Kasai T, Okabe M, Toyoda Y, Yanagimachi R. Mammalian transgenesis by intracytoplasmic sperm injection. Science 284: 1180-1183, 1999.
104. Pfeifer A. Lentiviral transgenesis. Transgenic Res 13: 513-522, 2004.
105. Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 99: 2140-2145, 2002.
106. Pion M, Jordan A, Biancotto A, Dequiedt F, Gondois-Rey F, Rondeau S, Vigne R, Hejnar J, Verdin E, Hirsch I. Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation. J Virol 77: 4025-4032, 2003.
107. Punzon I, Criado LM, Serrano A, Serrano F, Bernad A. Highly efficient lentiviral-mediated human cytokine transgenesis on the NOD/scid background. Blood 103: 580-582, 2004.
108. Qian Z, Haessler M, Lemos JA, Arsenault JR, Aguirre JE, Gilbert JR, Bowler RP, Park F. Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors. Mol Ther 13: 694-704, 2006.
109. Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci USA 93: 15266-15271, 1996.
110. Ritchie WA, Neil C, King T, Whitelaw CB. Transgenic embryos and mice produced from low titre lentiviral vectors. Transgenic Res 16: 661-664, 2007.
111. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Rooney DL, Ihrig MM, McManus MT, Gertler FB, Scott ML, Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406, 2003.
112. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, Zhang M, McManus MT, Gertler FB, Scott ML, Van Parijs L. Corrigendum: A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 39: 803, 2007.
113. Rulicke T, Hubscher U. Germ line transformation of mammals by pronuclear microinjection. Exp Physiol 85: 589-601, 2000.
114. Ryu BY, Orwig KE, Oatley JM, Lin CC, Chang LJ, Avarbock MR, Brinster RL. Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells. J Androl 28: 353-360, 2007.
115. Sandy P, Ventura A, Jacks T. Mammalian RNAi: a practical guide. Biotechniques 39: 215-224, 2005.
116. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529, 2002.
117. Scott BB, Lois C. Generation of tissue-specific transgenic birds with lentiviral vectors. Proc Natl Acad Sci USA 102: 16443-16447, 2005.
118. Segura MM, Garnier A, Durocher Y, Coelho H, Kamen A. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng. In press.
119. Singer O, Tiscornia G, Ikawa M, Verma IM. Rapid generation of knockdown transgenic mice by silencing lentiviral vectors. Nat Protoc 1: 286-292, 2006.
120. Smith K, Spadafora C. Sperm-mediated gene transfer: applications and implications. Bioessays 27: 551-562, 2005.
121. Snove O Jr, Rossi JJ. Expressing short hairpin RNAs in vivo. Nat Methods 3: 689-695, 2006.
122. Solter D. Mammalian cloning: advances and limitations. Nat Rev Genet 1: 199-207, 2000.
123. Stewart C, Harbers K, Jahner D, Jaenisch R. X chromosome-linked transmission and expression of retroviral genomes microinjected into mouse zygotes. Science 221: 760-762, 1983.
124. Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat Methods 3: 109-116, 2006.
125. Tajima S, Shinohara K, Fukumoto M, Zaitsu R, Miyagawa J, Hino S, Fan J, Akasaka K, Matsuoka M. Ars insulator identified in sea urchin possesses an activity to ensure the transgene expression in mouse cells. J Biochem (Tokyo) 139: 705-714, 2006.
126. Tesson L, Cozzi J, Menoret S, Remy S, Usal C, Fraichard A, Anegon I. Transgenic modifications of the rat genome. Transgenic Res 14: 531-546, 2005.
127. Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F, Gregory LG, Nivsarkar M, Themis M, Holder MV, Buckley SM, Dighe N, Ruthe AT, Mistry A, Bigger B, Rahim A, Nguyen TH, Trono D, Thrasher AJ, Coutelle C. Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. Mol Ther 12: 763-771, 2005.
128. Tiscornia G, Singer O, Ikawa M, Verma IM. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 100: 1844-1848, 2003.
129. Tiscornia G, Singer O, Verma IM. Production and purification of lentiviral vectors. Nat Protoc 1: 241-245, 2006.
130. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 7: 20-23, 2000.
131. van den Brandt J, Wang D, Kwon SH, Heinkelein M, Reichardt HM. Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo. Genesis 39: 94-99, 2004.
132. Van Maele B, De Rijck J, De Clercq E, Debyser Z. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J Virol 77: 4685-4694, 2003.
133. Verma IM, Weitzman MD. Gene therapy: twenty-first century medicine. Annu Rev Biochem 74: 711-738, 2005.
134. Wall RJ. Pronuclear microinjection. Cloning Stem Cells 3: 209-220, 2001.
135. Wall RJ, Kerr DE, Bondioli KR. Transgenic dairy cattle: genetic engineering on a large scale. J Dairy Sci 80: 2213-2224, 1997.
136. Wang GP, Ciuffi A, Leipzig J, Berry CC, Bushman FD. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17: 1186-1194, 2007.
137. Whitelaw CB, Radcliffe PA, Ritchie WA, Carlisle A, Ellard FM, Pena RN, Rowe J, Clark AJ, King TJ, Mitrophanous KA. Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector. FEBS Lett 571: 233-236, 2004.
138. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813, 1997.
139. Wolfgang MJ, Eisele SG, Browne MA, Schotzko ML, Garthwaite MA, Durning M, Ramezani A, Hawley RG, Thomson JA, Golos TG. Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos. Proc Natl Acad Sci USA 98: 10728-10732, 2001.
140. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751, 2003.
141. Yang SH, Agca Y, Cheng PH, Yang JJ, Agca C, Chan AW. Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus. Genesis 45: 177-183, 2007.
142. Zabner J, Wadsworth SC, Smith AE, Welsh MJ. Adenovirus-mediated generation of cAMP-stimulated Cl transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method. Gene Ther 3: 458-465, 1996.
143. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185, 2000.
144. Zhang B, Metharom P, Jullie H, Ellem KA, Cleghorn G, West MJ, Wei MQ. The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events. Genet Vaccines Ther 2: 6, 2004.
145. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886-2892, 1999.
146. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873-9880, 1998.